Pharmagen (OTC:PHRX) Stock, Quote.Headers.trade-ideas

Pharmagen Inc as a distributor of specialty drugs, compounding and admix pharmacy, and producer of over-the-counter branded multivitamins to the healthcare provider market. The company distributes hard-to-find and specialty drugs to the healthcare provider market throughout the United States, while functioning as an aggregator of real-time market demand for these products.

News

Intraday Update

Markets

Movers

Trading Ideas

ACLLF

AJINY

ANLKY

APCX

APYRF

ATAX

ATEYY

ATHHF

AUDC

Avadel Pharmaceuticals plc - American Depositary Shares each representing one Ordinary Share

AVDL

BASI

BGMZF

CACI

CELG

CLCT

CLNFF

CTVEF

CWCO

DLTR

DRRX

DTEMF

DYFSF

ELAMF

ENTG

EPRT

EVOA

FNWB

FRMC

FTMNF

GGGOF

GRBK

HALL

HEMA

HLTOF

ICAD

ITEPF

JACK

LIBE

LINK

LOMLF

LTDH

LYTS

MCDMF

MDCO

MRRTY

NILSY

NTDOF

NUPMF

PCHM

PIFFY

PLMR

PRKA

RILY

RLBY

RPAY

Rwe Ag Ord Bearer Dm5 American Depository Receipt

RWEOY

SEGXF

SNDD

SQNXF

SUWN

SWKH

TERP

TGONF

TPVG

TRNO

TRXD

UEIC

UGDIF

VNCE

YDVL

ZEAL

GLTVF

Stocks That Hit 52-Week Highs On Tuesday

Pharmagen Inc

MNSO

MINISO Says MINISO USA Achieved Staggering 250% Membership Growth in 2024, Underscoring Successful Localization Strategy

Macquarie analyst Eugene Hsiao downgrades XPeng (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XPEV#NYSE">XPEV</a>) from Outperform to Neutral and announces $18 price target.

Downgrades

Price Target

Analyst Ratings

XPEV

Macquarie Downgrades XPeng to Neutral, Announces $18 Price Target

Jeep Maker Stellantis N.V. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/STLA#NYSE">STLA</a>) shares are trading higher after the company boosted strategic partnerships with Mistral AI to expand the use of artificial intelligence across various functions, including vehicle<a target="_blank" href="https://www.benzinga.com/pressreleases/25/02/g43553628/stellantis-and-mistral-ai-strengthen-strategic-partnership-to-enhance-customer-experience-vehicle-" rel="noreferrer noopener"> engineering and in-car technology</a>.
By leveraging Mistral AI&#8217;s expertise in large language models and AI automation, the collaboration aims to enhance data analysis, optimize development processes, and improve customer engagement across Stellantis&#8217; operations.
Stellantis and Mistral AI are collaborating to develop an AI-driven in-car assistant that enables drivers to communicate with their vehicles using natural language.
This intelligent assistant acts as an interactive, voice-enabled user guide, allowing customers to ask about vehicle functions, troubleshoot issues, or understand warning indicators while receiving instant, conversational responses.
This initiative builds on more than a year of joint AI-driven projects focused on enhancing customer experience, product innovation, and manufacturing efficiency.
Read: <a target="_blank" href="https://www.benzinga.com/news/management/25/02/43429256/jeep-maker-stellantis-unveils-organizational-overhaul-stock-dips" rel="noreferrer noopener">Jeep Maker Stellantis Unveils Organizational Overhaul; Stock Dips</a>
Ned Curic, Stellantis Chief Engineering &amp; Technology Officer, said, &#8220;There are many players in the AI space, and we&#8217;re particularly happy to partner with Mistral AI for its strong ability to adapt quickly and drive meaningful results in a highly collaborative way.&#8221;&nbsp;
&#8220;Together, we are exploring AI&#8217;s potential across several domains to enhance our product development, customer experience and deliver real benefits.&#8221;
Arthur Mensch, Mistral AI CEO and Co-Founder, stated, &#8220;Stellantis&#8217; bold approach to technology, and its ability to integrate advanced AI into real-world driving experiences make it an ideal partner to showcase how Mistral AI&#8217;s versatile solutions can reinvent mobility and empower engineers in their work.&#8221;
Last month, Stellantis said it expects global total shipments to decline 9% year-over-year to around 1.395 million <a target="_blank" href="https://www.benzinga.com/25/01/43023028/stellantis-projects-9-shipment-decline-for-q4-amid-us-inventory-cuts" rel="noreferrer noopener">units&nbsp;for the fourth quarter of 2024</a>.
Also, the company makes plans to make major structural changes to improve decision-making and<a target="_blank" href="https://www.benzinga.com/news/management/25/02/43429256/jeep-maker-stellantis-unveils-organizational-overhaul-stock-dips" rel="noreferrer noopener"> execution across the company</a>.
Stellantis will release its 2024 results on Wednesday, February 26, 2025.
Price Action: STLA shares are up 1.39% at $13.12 premarket at the last check Friday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/politics/25/02/43434471/trumps-tariffs-hit-markets-natural-gas-spikes-mexican-peso-hits-2-year-lows-bitcoin-freefalls-the-outlook-is-unclear-analysts-warn" target="_blank" rel="noreferrer noopener">Trump&#8217;s Tariffs Hit Markets, Natural Gas Spikes, Mexican Peso Hits 2-Year Lows, Bitcoin Freefalls: &#8216;The Outlook Is Unclear,&#8217; Analysts Warn </a></li>
</ul>
Photo by Jonathan Weiss on Shutterstock.

Equities

Large Cap

Contracts

STLA

Jeep Maker Stellantis Expands AI Push With Mistral AI Partnership: Details

Proto Labs (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PRLB#NYSE">PRLB</a>) released its Q4 earnings on Friday, February 7, 2025 at 06:00 AM.
Here's what's important from the earnings announcement.
<h3>Earnings</h3>
Proto Labs beat estimated earnings by 19.0%, reporting an EPS of $0.38 versus an estimate of $0.32.
Revenue was down $3.30 million from the same period last year.
<h3>Analysis of Past Earnings</h3>
The company beat on EPS by $0.15 in the last quarter, resulting in a 39.0% increase share price change the following day.
Here's a look at Proto Labs's past performance:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q3 2024</th>
<th>Q2 2024</th>
<th>Q1 2024</th>
<th>Q4 2023</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>0.32</td>
<td>0.35</td>
<td>0.31</td>
<td>0.30</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>0.47</td>
<td>0.38</td>
<td>0.40</td>
<td>0.46</td>
</tr>
<tr>
<td>Revenue Estimate</td>
<td>121.38M</td>
<td>126.24M</td>
<td>124.68M</td>
<td>122.72M</td>
</tr>
<tr>
<td>Revenue Actual</td>
<td>125.62M</td>
<td>125.63M</td>
<td>127.89M</td>
<td>125.05M</td>
</tr>
</tbody>
</table>

New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).
<h3>Guidance</h3>
Proto Labs management provided guidance for Q1 2025, expecting earnings between $0.26 and $0.34 per share.
To track all earnings releases for Proto Labs <a href="https://www.benzinga.com/quote/PRLB/earnings">visit their earnings calendar here.</a> 
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Earnings

PRLB

Proto Labs Q4 Earnings Summary & Key Takeaways

Avantor (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AVTR#NYSE">AVTR</a>) released its Q4 earnings on Friday, February 7, 2025 at 06:05 AM.
Here's what's important from the earnings announcement.
<h3>Earnings</h3>
Avantor beat estimated earnings by 4.0%, reporting an EPS of $0.27 versus an estimate of $0.26.
Revenue was down $35.80 million from the same period last year.
<h3>Earnings History Overview</h3>
The company beat on EPS by $0.01 in the last quarter, resulting in a 4.0% drop share price change the following day.
Here's a look at Avantor's past performance:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q3 2024</th>
<th>Q2 2024</th>
<th>Q1 2024</th>
<th>Q4 2023</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>0.25</td>
<td>0.23</td>
<td>0.20</td>
<td>0.22</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>0.26</td>
<td>0.25</td>
<td>0.22</td>
<td>0.25</td>
</tr>
<tr>
<td>Revenue Estimate</td>
<td>1.73B</td>
<td>1.70B</td>
<td>1.68B</td>
<td>1.70B</td>
</tr>
<tr>
<td>Revenue Actual</td>
<td>1.71B</td>
<td>1.70B</td>
<td>1.68B</td>
<td>1.72B</td>
</tr>
</tbody>
</table>

To track all earnings releases for Avantor <a href="https://www.benzinga.com/quote/AVTR/earnings">visit their earnings calendar here.</a> 
This article was generated by Benzinga's automated content engine and reviewed by an editor.

AVTR

Avantor Q4 Earnings Report: What Investors Need to Know

On Thursday, February 6, U.S. markets closed mixed, with the S&amp;P 500 and Nasdaq gaining while the Dow slipped amid a volatile session. Investors assessed corporate earnings and awaited key economic reports. Amazon rose 1.1% before its earnings, beating revenue estimates but missing cloud sales, only to fall in the after hours. Eli Lilly, Tapestry, and Philip Morris surged on strong forecasts, while Honeywell fell on restructuring plans.
In economic data, U.S. initial jobless claims rose by 11,000 to 219,000 in the last week of January, exceeding the expected 213,000. Unit labor costs increased by 3.0% in Q4 after a 0.5% rise in Q3, while nonfarm business sector productivity grew 1.2%, down from a revised 2.3% in the prior quarter.
The S&amp;P 500 saw gains across most sectors, driven by consumer staples, technology, and financial stocks, while energy and healthcare lagged, closing lower.
The Dow Jones Industrial Average was down 0.28% and closed at 44,747.63, the S&amp;P 500 closed higher by 0.36% at 6,083.57, and the Nasdaq Composite rose 0.51% to finish at 19,791.99.
Aisa Markets Today
<ul>
<li>On Friday, Japan&#8217;s Nikkei 225 closed lower by 0.60% at 38,819.00, led by losses in the Communication, Automobiles &amp; Parts and Machinery sectors.</li>
<li>Australia&#8217;s S&amp;P/ASX 200 declined 0.11% to 8,511.40, led by losses in the Energy, Gold and Healthcare sectors.</li>
<li>India&#8217;s Nifty 50 closed lower by 0.18% at 23,561.25, and the Nifty 500 slid 0.14%, closing at 21,641.15. The losses were led by losses in the Oil and gas, Fast-Moving Consumer Goods, and Healthcare sectors.</li>
<li>China&#8217;s Shanghai Composite rose 1.01% and closed at 3,303.67, while Shanghai Shenzhen CSI 300 rose 1.30% at 3,892.70.</li>
<li>Hong Kong&#8217;s Hang Seng closed the session higher by 1.16% at 21,133.54.</li>
</ul>
Eurozone at 05:30 AM ET
<ul>
<li>The European STOXX 50 was down 0.23%.</li>
<li>Germany&#8217;s DAX rose 0.04%.</li>
<li>France&#8217;s CAC declined 0.16%.</li>
<li>U.K.&#8217;s FTSE index 100 traded lower by 0.24%</li>
</ul>
Commodities at 05:30 AM ET
<ul>
<li>Crude Oil WTI was trading higher by 0.79% at $71.17/bbl, and Brent was up 0.81% at $74.90/bbl.</li>
<li>Oil prices rose after new U.S. sanctions on Iran but remained on track for a third consecutive weekly decline due to trade war concerns.</li>
<li>Natural Gas declined 0.73% to $3.383.</li>
<li>Gold was trading higher by 0.51% at $2,891.51, Silver was up 0.28% to $32.722, and Copper rose 1.30% to $4.5198.</li>
</ul>
U.S. Futures at 05:30 AM ET
Dow futures were up 0.06%, S&amp;P 500 futures declined 0.01% and Nasdaq 100 futures slid 0.04%.
Forex at 05:30 AM ET
<ul>
<li>The U.S. Dollar Index gained 0.04% to 107.74, USD/JPY was up 0.49% to 152.09, and USD/AUD fell 0.09% to 1.5899.</li>
<li>The U.S. dollar held steady ahead of payroll data, while the yen hit a nine-week high on BoJ rate hike bets. Markets eye U.S. job figures and Fed policy, while geopolitical tensions and trade developments add uncertainty.</li>
</ul>
Photo by Pavel Bobrovskiy via Shutterstock

Asia

Emerging Markets

Eurozone

Futures

Commodities

Forex

ADIV

AGOV

ASHR

BBEU

BOIL

CQQQ

PowerShares DBmmodity Index Optimum Yield Diversified Fund

EEMA

FLAX

CurrencyShares British Pound Sterling Trust

IEMG

IEUR

KraneShares Trust KraneShares S&P Pan Asia Dividend Aristocrats Index ETF

KDIV

SPEM

USDU

PowerShares DB US Dollar Index Bullish Fund

Asia And Europe Markets Mixed; Dollar Steady Ahead of Key Data - Global Markets Today While US Slept

AGC (OTC:<a class="ticker" href="https://www.benzinga.com/stock/ASGLY#OTC">ASGLY</a>) is looking for FY2025 GAAP EPS of $2.48. sees sales of $14.117 billion.

Guidance

ASGLY

AGC Sees FY2025 Earnings Per ADS US$0.50; Sees Sales $14.117B

<a href="https://www.bloomberg.com/news/articles/2025-02-07/emirates-grows-more-cautious-on-boeing-777x-timeline-amid-delays?sref=2h1zKciy" title="https://www.bloomberg.com/news/articles/2025-02-07/emirates-grows-more-cautious-on-boeing-777x-timeline-amid-delays?sref=2h1zKciy">https://www.bloomberg.com/news/articles/2025-02-07/emirates-grows-more-cautious-on-boeing-777x-timeline-amid-delays?sref=2h1zKciy</a>

Bloomberg Reported Emirates Now Expects 777x Deliveries To Be Pushed Back Until At Least The Second Quarter Of 2027

Johnson Rice analyst Martin Malloy initiates coverage on GE Vernova (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GEV#NYSE">GEV</a>) with a Buy rating and announces Price Target of $425.

Initiation

Johnson Rice Initiates Coverage On GE Vernova with Buy Rating, Announces Price Target of $425

Mitsubishi Estate Co (OTC:<a class="ticker" href="https://www.benzinga.com/stock/MITEY#OTC">MITEY</a>) Mitsubishi Estate Co Mitsubishi Estate Co FY2024 GAAP EPS Guidance JPY 137.93 and FY2024 Sales Guidance JPY 1596B

MITEY

Mitsubishi Estate Co FY2024 GAAP EPS Guidance JPY 137.93 and FY2024 Sales Guidance JPY 1596B

Danske Bank (OTC:<a class="ticker" href="https://www.benzinga.com/stock/DNKEY#OTC">DNKEY</a>) reported quarterly earnings of $0.51 per share. This is a 6.25 percent increase over earnings of $0.48 per share from the same period last year. The company reported $2.08 billion in sales this quarter. This is a 4.46 percent increase over sales of $2.00 billion the same period last year.

DNKEY

Danske Bank Q4 GAAP EPS $0.51 Up From $0.48 YoY, Sales $2.08B Up From $2.00B YoY

AGC (OTC:<a class="ticker" href="https://www.benzinga.com/stock/ASGLY#OTC">ASGLY</a>) reported quarterly earnings of $0.08 per share. This is a 28.33 percent increase over earnings of $0.06 per share from the same period last year. The company reported $3.50 billion in sales this quarter. This is a 3.37 percent decrease over sales of $3.62 billion the same period last year.

AGC Q4  Earnings Per ADS $0.08 Up From $0.06 YoY, Sales $3.50B Down From $3.62B YoY

Piper Sandler analyst Clarke Jeffries reiterates BILL Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BILL#NYSE">BILL</a>) with a Overweight and maintains $85 price target.

Reiteration

BILL

Piper Sandler Reiterates Overweight on BILL Holdings, Maintains $85 Price Target

New Stock Repurchase Program
On February 4, 2025, Protolabs' board of directors approved a new $100 million stock repurchase program.
Under the stock repurchase program, shares of the Company's common stock may be repurchased periodically, including in the open market or privately negotiated transactions. The actual timing, manner, number, and value of shares repurchased under the program will be determined by management at its discretion and will depend on several factors, including the market price of Protolabs' common stock, general market and economic conditions, applicable requirements, and other business considerations. The stock repurchase program does not obligate the Company to acquire any particular amount of shares of the Company's common stock. The new program is open-ended and remains in effect until the total authorized amount is expended or until further action by the board of directors.

Buybacks

Protolabs Announces $100M Stock Repurchase Program; Open-Ended Buyback Approved By Board

The most oversold stocks in the industrials sector presents an opportunity to buy into undervalued companies.
The RSI is a momentum indicator, which compares a stock&#8217;s strength on days when prices go up to its strength on days when prices go down. When compared to a stock&#8217;s price action, it can give traders a better sense of how a stock may perform in the short term. An asset is typically considered oversold when the <a href="https://www.benzinga.com/topic/rsi">RSI is below 30</a>, according to <a href="https://pro.benzinga.com/">Benzinga Pro</a>.
Here's the latest list of major oversold players in this sector, having an RSI near or below 30.
<h3 class="wp-block-heading">Regal Rexnord Corp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RRX#NYSE">RRX</a>)</h3>
<ul>
<li>On Feb. 5, Regal Rexnord posted weaker-than-expected quarterly results. CEO Louis Pinkham commented, &#8220;In the fourth quarter, our team continued to make good progress on our many growth, margin, and debt reduction initiatives, despite weaker-than-expected end markets. Most notably, our IPS segment continued to leverage its unrivaled scale and scope to achieve solid outgrowth and healthy margin gains, with adjusted EBITDA margins up two points versus prior year, to 26.0%.&#8221; The company' stock fell around 12% over the past five days and has a <a href="https://www.benzinga.com/quote/RRX">52-week low of $130.94</a>.</li>
<li>RSI Value: 28.2&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</li>
<li>RRX Price Action: Shares of Regal Rexnord fell 7.9% to close at $142.87 on Thursday.</li>
<li>Benzinga Pro's real-time newsfeed alerted to latest <a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent020725&amp;t=be2bearmibe3na1">RRX news</a>. </li>
</ul>
<figure class="wp-block-image is-resized"><a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent020725&amp;t=be2bearmibe3na1"><img decoding="async" src="blob:https://editorial.benzinga.com/711a2113-2435-4b55-89d6-b323e1a61af4" alt="" style="width:512px;height:auto" /></a></figure>
<h3 class="wp-block-heading">Deluxe Corp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DLX#NYSE">DLX</a>)</h3>
<ul>
<li>On Feb. 5, Deluxe reported worse-than-expected fourth-quarter sales results and issued FY25 revenue guidance below estimates.. The company's stock fell around 15% over the past five days and <a href="https://www.benzinga.com/quote/DLX">has a 52-week low</a> of $18.48.</li>
<li>RSI Value: 21.6</li>
<li>DLX Price Action: Shares of Deluxe dipped 11.3% to close at $20.02 on Thursday.</li>
<li>Benzinga Pro&#8217;s charting tool helped identify the trend in <a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent020725&amp;t=be2bearmibe3na1">DLX stock</a>. </li>
</ul>
<figure class="wp-block-image is-resized"><a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent020725&amp;t=be2bearmibe3na1"><img decoding="async" src="blob:https://editorial.benzinga.com/a189218a-07f0-4861-b481-909d070e0623" alt="" style="width:527px;height:auto" /></a></figure>
<h3 class="wp-block-heading">Kennametal Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KMT#NYSE">KMT</a>)</h3>
<ul>
<li>On Feb. 5, Kennametal reported worse-than-expected second-quarter financial results. &#8220;This quarter we once again generated strong cash flow from operations,&#8221; said Sanjay Chowbey, President and CEO. &#8220;However, conditions in a number of our end markets, primarily in EMEA, continued to weaken resulting in sales at the lower end of our expectations.&#8221; The company's stock fell around 9% over the past five days and has a 52-week <a href="https://www.benzinga.com/quote/KMT">low of $20.50</a>.</li>
<li>RSI Value: 22</li>
<li>KMT Price Action: Shares of Kennametal fell 3.1% to close at $21.97 on Thursday.</li>
<li>Benzinga Pro&#8217;s signals feature notified of a potential breakout in <a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent020725&amp;t=be2bearmibe3na1">KMT shares</a>. </li>
</ul>
<figure class="wp-block-image size-full is-resized"><a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent020725&amp;t=be2bearmibe3na1"><img loading="lazy" decoding="async" width="887" height="825" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/07040135/image-63.png" alt="" class="wp-image-771143" style="width:507px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/07040135/image-63.png 887w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/07040135/image-63-300x279.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/07040135/image-63-768x714.png 768w" sizes="(max-width: 887px) 100vw, 887px" /></a></figure>
Read This Next: 
<ul>
<li><a href="https://www.benzinga.com/trading-ideas/long-ideas/25/02/43526669/jim-cramer-says-dont-buy-this-financial-stock-at-this-level-let-it-come-in">Jim Cramer Says Don&#8217;t Buy This Financial Stock At This Level: &#8216;Let It Come In&#8217;</a></li>
</ul>

Long Ideas

Pre-Market Outlook

Top 3 Industrials Stocks That May Explode This Quarter

JP Morgan analyst Richard Choe downgrades BCE (TSX:<a class="ticker" href="https://www.benzinga.com/stock/BCE#TSX">BCE</a>) from Neutral to Underweight and lowers the price target from C$35 to C$29.

TSX:BCE

JP Morgan Downgrades BCE to Underweight, Lowers Price Target to C$29

ORCL

Defiance ETFs Unveils ORCX, The First 2X Long ETF For Oracle Corporation; ORCX Seeks To Provide 200% Long Daily Targeted Exposure To Oracle Corporation

First Quarter 2025 Outlook
In the first quarter of 2025, the Company expects to generate revenue between $120 million and $128 million.
The Company expects first quarter 2025 diluted net income per share between $0.08 and $0.16, and non-GAAP diluted net income per share between $0.26 and $0.34

Proto Labs Q1 2025 Outlook: Revenue Forecast at $120M–$128M Vs. $124.51M Est.; And Sees Non-GAAP EPS Of $0.26–$0.34 Vs. $0.34 Est.

Avantor (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AVTR#NYSE">AVTR</a>) reported quarterly earnings of $0.27 per share which beat the analyst consensus estimate of $0.26 by 3.85 percent. This is a 8 percent increase over earnings of $0.25 per share from the same period last year. The company reported quarterly sales of $1.69 billion which missed the analyst consensus estimate of $1.71 billion by 1.36 percent. This is a 2.10 percent decrease over sales of $1.72 billion the same period last year.

Avantor Q4 2024 Adj EPS $0.27 Beats $0.26 Estimate, Sales $1.69B Miss $1.71B Estimate

Mitsubishi Estate Co (OTC:<a class="ticker" href="https://www.benzinga.com/stock/MITEY#OTC">MITEY</a>) reported quarterly earnings of $0.29 per share. This is a 52.63 percent increase over earnings of $0.19 per share from the same period last year. The company reported $2.67 billion in sales this quarter. This is a 16.59 percent increase over sales of $2.29 billion the same period last year.

Mitsubishi Estate Co Q3 EPS USD$0.29 Up From USD$0.19 YoY, Sales USD$2.67B Up From USD$2.29B YoY

Pharmagen

Comments

Pharmagen

Pharmagen (PHRX) Forecast

Pharmagen (OTC:PHRX) Stock, Quote.Headers.trade-ideas

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga